Abstract
The purpose of this book is to collect in a single volume pertinent material about ovarian malignancy that is either new or in which there has been a change in traditional concepts in terms of contemporary findings and knowledge. To accomplish this goal, it was necessary first to identify the problems associated with ovarian cancer and then to suggest solutions in light of the present phase of medical development. This chapter identifies problems related to ovarian cancer but does not discuss them in detail. The detailed discussions are included in the appropriate chapters.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Barber HRK: CA 36 (3): 149, 1986.
Barber HRK: Foreword—ovarian tumors. Clin Obstet Gynepol 12: 292, 1969.
Barber HRK, Graber EA: The PMPO syndrome (postmenopausal palpable ovary syndrome). Obstet Gynecol 38: 921, 1971.
Barnhill DR, O’Connor DM: Management of ovarian neoplasms of low malignant potential. Oncology 5 (4): 21, 1991.
Bennington JL, Ferguson BR, Harber SL: Incidence and relative frequency of benign and malignant ovarian neoplasms. Obstet Gynecol 32: 627, 1968.
Biskind MS, Biskind GR: Development of tumors in rat ovary after transplantation into the spleen. Proc Soc Exp Biol Med 55: 176, 1944.
Cancer Facts and Figures 1991. American Cancer Society, Atlanta.
Furth J, Sobel H: Neoplastic transformation of granulosa cells in grafts of normal ovaries into spleens of gonadectomized mice. J Nat Cancer Inst 8: 7, 1948.
Gibbs EK: Suggested prophylaxis for ovarian cancer: a 20-year report from cases at Butterworth Hospital. Am J Obstet Gynecol 111: 756, 1971.
Heintz APM, Hacker NF, Berek JS, et al: Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 67: 783, 1986.
Hollinshead AC: Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma. Cancer 36: 1288, 1975.
Hoskins WJ: The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer. Baillieres Clin Obstet Gynecol 3: 59, 1989.
James PD: Epidemiology of ovarian cancer. Lancet 1: 412, 1974.
Jones TC, Gilmore CE: The ovaries in animals. In The Ovary. Grady HG, Smith DE (eds): Williams & Wilkins, Baltimore, 1963, p. 255.
Lingeman CH: Etiology of cancer of the human ovary. J Natl Cancer Inst 53: 1603, 1974.
Myers NA, Gloeckler Ries LA: Cancer patient survival rates: SEER program results for 10 years of follow up. CA 39 (1): 21, 1989.
Oran TJ: Is the appendectomy essential in the treatment of ovarian cancer? Surg Forum 39: 469, 1988.
Randall CL, Hall DW, Armenia CS: Pathology in the preserved ovary after unilateral oophorectomy. Am J Obstet Gynecol 84: 1233, 1962.
Silverberg E, Lubera JA: Cancer statistics 1989. CA 39 (1): 3, 1989.
Stone ML, Weingold A, Sanford S, Sonnenblick B: Factors affecting patients with ovarian carcinoma. Surg Gynecol Obstet 116: 351, 1963.
Terz JJ, Barber HRK, Brunschwig A: Incidence of carcinoma in the retained ovary. Am J Surg 113: 511, 1967.
West RO: Epidemiologic studies of malignancies of the ovaries. Cancer 19: 1001, 1966.
Wynder EL, Dodo H, Barber HRK: Epidemiology of cancer of the ovary. Cancer 23: 352, 1969.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Barber, H.R.K. (1993). Introduction. In: Ovarian Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9232-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9232-3_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9234-7
Online ISBN: 978-1-4613-9232-3
eBook Packages: Springer Book Archive